Cargando...
Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants
PURPOSE: More than a third of primary breast cancer patients are treated with cytotoxic chemotherapy, typically without guidance from predictive markers. Increased use of neoadjuvant chemotherapy provides opportunities for identification of molecules associated with treatment response, by comparing...
Gardado en:
| Publicado en: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497675/ https://ncbi.nlm.nih.gov/pubmed/32734521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05836-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|